Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.| ProMarket
Over the last year, the United States government has demonstrated increased concern about private equity’s involvement in health care. Barak Richman and Richard Scheffler discuss why the government’s actions have not yet matched the energy of its words and how academics and policymakers must continue to investigate private equity’s influences as they devise policy to […]| ProMarket
Eleanor Fox writes that the paradigm shift in United States antitrust is not best understood as an embrace of neo-Brandeisian anti-bigness ideas but rather a rejection of neoliberal principles that have prevented effective antitrust regulation for decades. The shift encompasses the concerns and efforts of centrists, progressives, and neo-Brandeisians.| ProMarket
ProMarket is the publication of the George J. Stigler Center for the Study of the Economy and the State at the University of Chicago Booth School of Business. ProMarket is an academic forum focused on topics of special interest capture, antitrust, political economy, and the future of capitalism. Economists have become increasingly technical and specialized, […]| ProMarket
Dear Fellow Shareholders,| www.jpmorganchase.com
